Coherus Oncology, Inc. Common Stock
CHRS
CHRS
201 hedge funds and large institutions have $1.23B invested in Coherus Oncology, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 53 increasing their positions, 73 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
201
Holders Change
+14
Holders Change %
+7.49%
% of All Funds
3.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
39
Increased
53
Reduced
73
Closed
22
Calls
$1.14M
Puts
$726K
Net Calls
+$415K
Net Calls Change
+$903K
Top Buyers
| 1 |
1
AllianceBernstein
Nashville,
Tennessee
|
$91.1M |
| 2 |
SCM
2
Suvretta Capital Management
New York
|
$19.5M |
| 3 |
PA
3
Perceptive Advisors
New York
|
$86.3M |
| 4 |
4
Point72 Asset Management
Stamford,
Connecticut
|
$5.27M |
| 5 |
5
BlackRock
New York
|
$190M |
